Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the single-dose bioequivalence of KUDCO's and Wyeth
Pharmaceuticals' (Protonix) 40 mg pantoprazole sodium delayed-lease tablets, under fed
conditions.